Medeon Biodesign (6499) — Cash Flow Quality Index
Medeon Biodesign (6499) has a Cash Flow Quality Index of 0.90x as of March 2022. Operating cash flow of NT$60.74 Million is below net income of NT$67.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Medeon Biodesign cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medeon Biodesign Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for Medeon Biodesign across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Medeon Biodesign (6499) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Medeon Biodesign (2018–2021)
Year-by-year earnings quality comparison for Medeon Biodesign. For live market cap and the full company financial profile, see Medeon Biodesign stock valuation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.14x | NT$-293.38 Million | NT$2.08 Billion | ▼ -111.2% |
| 2018 | 1.26x | NT$322.05 Million | NT$256.60 Million | — |